Adenocarcinoma of the Pancreas Active Not Recruiting Phase 1 / 2 Trials for Erlotinib (DB00530)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00769483MK-0646 and Gemcitabine +/- Erlotinib for Patients With Advanced Pancreatic CancerTreatment